Skip to main content
ALMONDZ · Financials · 2026-08-07

Almondz Global Securities Ltd

Stage 4 · wk 10In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹14.5
+0.84% today
₹253 Cr · Micro cap
About this companyFinancials· Investment Banking & Brokerage
Expand ▾

Almondz Global Securities Limited provides professional advisory and consultancy services in India. The company operates through Debt and Equity Market Operations, Corporate Finance/Advisory Fees, Wealth Advisory/Broking Activities, Finance Activities, Infrastructure Advisory, and Healthcare Services segments. It offers merchant banking, underwriting commission, corporate and loan syndication, and debts/bonds arrangement services, as well as deals/trades in shares and bonds. The company also provides broking and commission services for mutual funds, equity initial public offerings, capital gain bonds, government undertaking fixed deposits, and RBI taxable bonds, as well as stock and share broking services and other related ancillary services. In addition, it grant loans; and advisory services in relation to infrastructure projects. Further, the company operates an eye-care hospitals. Additionally, it provides private equity, M and A, infrastructure advisory, equity broking, wealth management, and debt portfolio management services and distribution; and technical and consultancy services in the areas of management, engineering, industrial, technical, and financial for infrastructure sectors. The company also operates commodity trading platforms for retail and corporate investors; engages in the real estate and healhcare activities, as well as provision of diagnostic and treatment services for various eye disorders. The company was incorporated in 1994 and is based in New Delhi, India. Almondz Global Securities Limited operates as a subsidiary of Avonmore Capital & Management Services Limited.

Visit company website →
P/E (TTM)
8.0
Forward —
Earnings Growth (YoY)
-22.2%
Revenue +6.7%
ROE
+10.7%
Profit margin +14.8%
vs 52W High
-32.7%
₹11.3 lo₹21.5 hi
32.7% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 10
1w13w26w
Week 10 — established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-5.3%
200 DMA: ₹15.3 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.62x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↑ ⇈
Accelerating · MA20 +3.3% vs MA50 -5.5% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Financials
↑ Building
Stage 2%
38.9%
20d Δ
+3.7pp
1M return
+1.0%
3M return
+0.4%
Sector Stage-2 % · last 20 days
Sector has 87 Stage 2 leaders. See Financials Stage 2 →
Industry
Investment Banking & Brokerage
↑ Building
Stage 2%
29.6%
20d Δ
+4.5pp
1M return
-1.7%
3M return
+1.4%
Industry Stage-2 % · last 20 days
Industry has 12 Stage 2 leaders. See Investment Banking & Brokerage Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 16w
S2 21w
S4 21w
S4 34w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 9w → S2 13w → S3 8w → S2 16w → S3 8w → S2 21w → S3 10w → S2 6w → S3 2w → S4 21w → S1 5w → S4 34w → S1 4w → S4 9w current
Total tracked: 168 weeks across 14 stage runs.
1M
+9.0%
3M
-15.3%
6M
+2.3%
YTD
-17.7%
1Y
-33.0%
Scan Membership
Breakout Watch
Latest: 2025-01-06
2 appearances in last 60 days. First seen: 2024-05-30.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S4
Wk 10 · Vol x
2026-08-06S4
Wk 9 · Vol x
2026-08-05S4
Wk 9 · Vol x
2026-08-04S4
Wk 9 · Vol x
2026-08-03S4
Wk 9 · Vol x
2026-07-31S4
Wk 9 · Vol x
2026-07-30S4
Wk 8 · Vol x
2026-07-29S4
Wk 8 · Vol x
2026-07-28S4
Wk 8 · Vol x
2026-07-27S4
Wk 8 · Vol x
2026-07-24S4
Wk 8 · Vol x
2026-07-23S4
Wk 7 · Vol x
Sector Peers — Stage 2All →
TFCILTD
wk 24 · 0.0% from hi
9.8
CONSOFINVT
wk 9 · -5.1% from hi
8.6
JSFB
wk 10 · -6.1% from hi
8.5
UJJIVANSFB
wk 8 · -2.7% from hi
8.4
TMB
wk 39 · -2.0% from hi
8.3
Moving averages & range
50 DMA
₹13.4
200 DMA
₹15.3
52W High
₹21.5
52W Low
₹11.3
5D Low
₹13.7
Resistance levels (recent highs)
20d High
₹15.1
60d High
₹15.2
120d High
₹17.4
250d High
₹21.5
Next resistance
+4.1%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.